Statement Of Cash Flows [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183196

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
74 387 EUR
80 025 EUR
Cash flows from (used in) investing activities [abstract]
Proceeds from sales of property, plant and equipment, classified as investing activities
- EUR
23,000 EUR
Purchase of property, plant and equipment, classified as investing activities
11 483 EUR
10 645 EUR
Purchase of intangible assets, classified as investing activities
9 699 EUR
5 585 EUR
Cash flows from (used in) investing activities
54 682 EUR
16 207 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
9 213 EUR
65,731,000 EUR
Payments of lease liabilities, classified as financing activities
7 193 EUR
3 475 EUR
Proceeds from government grants, classified as financing activities
41,000 EUR
5 835 EUR
Interest paid, classified as financing activities
11 765 EUR
3 503 EUR
Cash flows from (used in) financing activities
23 245 EUR
185 187 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
21,000 EUR
- EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
105 824 EUR
88 954 EUR
Cash and cash equivalents
32,872,000 EUR
138,675,000 EUR
49,720,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.